Glioblastoma — clinical trials in Sweden
8 open options
- TRIALPHASE3RECRUITING
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
SonoCloud-9 (SC9) · Carboplatin · Lomustine — 55 sites
- TRIALPHASE3RECRUITING
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Temozolomide · Lomustine — 20 sites
- TRIALPHASE2RECRUITING
Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
Salovum/SPC flakes — 1 site
- TRIALPHASE2RECRUITING
Surgery for Recurrent Glioblastoma
Surgery followed by adjuvant second-line therapy · Second-line therapy alone — 25 sites
- TRIALPHASE2 / PHASE3RECRUITING
Antisecretory Factor Glioblastoma Phase 2
Salovum · Placebo egg yolk powder — 1 site
- TRIALPHASE2RECRUITING
Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma
Salovum — 1 site
- TRIALPHASE1 / PHASE2RECRUITING
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
BAY 3713372 — 60 sites
- TRIALPHASE2RECRUITING
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Plixorafenib — 70 sites
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.